Last Price
288.93
Today's Change
+0.32 (0.11%)
Day's Change
287.16 - 289.70
Trading Volume
599,950
Market Cap
139 Billion
Shares Outstanding
484 Million
Avg Volume
650,627
Avg Price (50 Days)
300.88
Avg Price (200 Days)
290.72
PE Ratio
36.67
EPS
7.88
Earnings Announcement
12-Feb-2025
Previous Close
288.61
Open
287.64
Day's Range
287.16 - 289.7
Year Range
228.65 - 313.55
Trading Volume
599,950
1 Day Change
0.11%
5 Day Change
1.38%
1 Month Change
-4.68%
3 Month Change
-3.61%
6 Month Change
3.17%
Ytd Change
0.22%
1 Year Change
15.82%
3 Year Change
0.79%
5 Year Change
20.59%
10 Year Change
290.24%
Max Change
34851.07%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.